Q4 2025 · 13F-HR
ACT CAPITAL MANAGEMENT, LLCholdings as filed
Filed 2026-02-17 · accession 0001636587-26-000006
$123.7M
Reported value
58
Positions
2025-12-31
Period end
The Brief · ACT CAPITAL MANAGEMENT, LLC · Q4 2025
AI · grounded in 13F
ACT CAPITAL MANAGEMENT, LLC established a new position in ABVX with an investment of $8.6M. The fund also opened new stakes in TGTX for $8.0M and VKTX for $7.2M. Additionally, the manager increased its holding in CVX by 248.8%. The fund closed several positions, including AXSM and ADTN.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $14.9M | 12.1% | 60,500 | Common | SOLE |
| 166764100 | CVX | CHEVRON CORP NEW | $12.0M | 9.67% | 78,500 | Common | SOLE |
| 30231G102 | XOM | EXXON MOBIL CORP | $9.9M | 8.03% | 82,500 | Common | SOLE |
| 00370M103 | ABVX | ABIVAX | $8.6M | 6.97% | 63,900 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $8.0M | 6.48% | 268,875 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $7.3M | 5.86% | 206,100 | Common | SOLE |
| 15102K100 | CELC | CELCUITY INC | $6.3M | 5.11% | 63,415 | Common | SOLE |
| 023135106 | AMZN | AMAZON.COM INC | $5.7M | 4.59% | 24,600 | Common | SOLE |
| 67080N101 | NUVB | NUVATION BIO INC | $5.5M | 4.42% | 610,500 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS INC | $5.0M | 4.03% | 75,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $4.1M | 3.31% | 64,500 | Common | SOLE |
| 8049179QM | — | CELCUITY INC COM MAR 20 26 $50 CALL (CELC) | $3.0M | 2.46% | 30,500 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $2.7M | 2.17% | 38,500 | Common | SOLE |
| 389637109 | GBTC | GRAYSCALE BITCOIN TRUST ETF | $2.4M | 1.90% | 34,400 | Common | SOLE |
| 349381103 | FIGR | FIGURE TECHNOLOGY SOLUTIONS, INC | $2.3M | 1.90% | 57,500 | Common | SOLE |
| L8681T102 | SPOT | SPOTIFY TECHNOLOGY S.A. | $2.3M | 1.88% | 4,000 | Common | SOLE |
| 29273V100 | ET | ENERGY TRANSFER L P | $2.2M | 1.77% | 133,100 | Common | SOLE |
| 640268306 | NKTR | NEKTAR THERAPEUTICS | $2.2M | 1.75% | 51,200 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $1.3M | 1.08% | 53,500 | Common | SOLE |
| 459200101 | IBM | INTERNATIONAL BUS MACH CORP | $1.3M | 1.08% | 4,500 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $1.3M | 1.04% | 55,500 | Common | SOLE |
| 8049179KG | — | CELCUITY INC COM MAR 20 26 $35 CALL (CELC) | $1.2M | 1.01% | 12,500 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $1.2M | 0.96% | 82,500 | Common | SOLE |
| 093712107 | BE | BLOOM ENERGY CORP | $1.1M | 0.91% | 13,000 | Common | SOLE |
| 93627C101 | HCC | WARRIOR MET COAL INC | $1.1M | 0.86% | 12,000 | Common | SOLE |
| 26875P101 | EOG | EOG RESOURCES INC | $1.1M | 0.85% | 10,000 | Common | SOLE |
| 80004C200 | SNDK | SANDISK CORP | $830,830 | 0.67% | 3,500 | Common | SOLE |
| 25179M103 | DVN | DEVON ENERGY CORP | $805,860 | 0.65% | 22,000 | Common | SOLE |
| 90364P105 | PATH | UIPATH INC CL A | $770,330 | 0.62% | 47,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $767,821 | 0.62% | 73,900 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES | $717,830 | 0.58% | 23,000 | Common | SOLE |
| 76029N106 | REPL | REPLIMUNE GROUP INC | $597,780 | 0.48% | 61,500 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $528,600 | 0.43% | 12,000 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $528,360 | 0.43% | 7,000 | Common | SOLE |
| 44952J104 | CRGY | CRESCENT ENERGY COMPANY | $514,408 | 0.42% | 61,312 | Common | SOLE |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $390,180 | 0.32% | 3,000 | Common | SOLE |
| 696389402 | PALI | PALISADE BIO INC | $352,500 | 0.29% | 150,000 | Common | SOLE |
| 02074J501 | ACOG | ALPHA COGNITION INC | $334,750 | 0.27% | 51,500 | Common | SOLE |
| 53635D202 | LQDA | LIQUIDIA CORPORATION | $293,165 | 0.24% | 8,500 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $235,940 | 0.19% | 25,100 | Common | SOLE |
| 05614L209 | BW | BABCOCK & WILCOX ENTERPRISES | $231,410 | 0.19% | 36,500 | Common | SOLE |
| 01438T106 | ALDX | ALDEYRA THERAPEUTICS | $212,380 | 0.17% | 41,000 | Common | SOLE |
| N85083108 | NKLR | TERRA INNOVATUM GLOBAL N V | $207,900 | 0.17% | 45,000 | Common | SOLE |
| 74006W207 | PRAX | PRAXIS PRECISION MEDICINES INC | $206,318 | 0.17% | 700 | Common | SOLE |
| 29664W105 | ESPR | ESPERION THERAPEUTICS INC | $175,750 | 0.14% | 47,500 | Common | SOLE |
| 53229C107 | LSPD | LIGHTSPEED COMMERCE INC | $151,000 | 0.12% | 12,500 | Common | SOLE |
| 23954D109 | DAWNGBX | DAY ONE BIOPHARMACEUTICALS INC | $120,228 | 0.10% | 12,900 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $114,630 | 0.09% | 3,000 | Common | SOLE |
| 03237H101 | AMLX | AMYLYX PHARMACEUTICALS INC | $108,720 | 0.09% | 9,000 | Common | SOLE |
| 962166104 | WY | WEYERHAEUSER CO MTN BE | $106,605 | 0.09% | 4,500 | Common | SOLE |
| M85548101 | SSYS | STRATASYS LTD | $86,800 | 0.07% | 10,000 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD COM NPV | $84,675 | 0.07% | 7,500 | Common | SOLE |
| 389930207 | BTC | GRAYSCALE BITCOIN MINI TR ETF | $69,714 | 0.06% | 1,800 | Common | SOLE |
| 14070B309 | CAPR | CAPRICOR THERAPEUTICS INC | $43,290 | 0.04% | 1,500 | Common | SOLE |
| 29415J106 | NVNO | ENVVENO MED CORP COM | $36,892 | 0.03% | 115,000 | Common | SOLE |
| 98459U103 | YALA | YALLA GROUP LTD | $34,700 | 0.03% | 5,000 | Common | SOLE |
| 70465T107 | PDSB | PDS BIOTECHNOLOGY CORP | $23,094 | 0.02% | 30,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $19,770 | 0.02% | 1,500 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.